Our Expert in Germany
No results available
Director liability m&a germany sits at the sharp end of every German transaction in 2026, because the person who signed the accounts, approved a payment or filed (or failed to file) for insolvency can remain personally exposed long after completion. Heightened foreign investment scrutiny under the Außenwirtschaftsverordnung and Außenwirtschaftsgesetz, tighter D&O terms after a run of insurer losses, and increasingly aggressive post-closing claims practice have made risk allocation a first-order commercial issue, not an afterthought buried in the miscellaneous clauses. This guide takes a clear position on how buyers and sellers should split that risk between seller indemnities, warranty and indemnity (W&I) insurance, D&O run-off and wrap cover, and escrow.
It is written for in-house counsel, private equity sponsors, deal principals and M&A lawyers who need a decision, not a hedge. Read it as a playbook: the comparison table and decision framework tell you what to choose and when.
Search intent in brief: This article helps M&A counsel, in-house teams, private equity and sellers choose how to allocate post-deal director liability in German share and asset deals. It compares indemnities, W&I, D&O insurance and wraps, and escrows, and provides negotiation checklists and sample SPA language.
A share deal transfers the company, not the personal exposure of the people who ran it. Directors remain liable for their own conduct, and a change of ownership does not extinguish claims that crystallised before completion. Understanding director liability in German M&A therefore starts with the statutory duty regime.
For the GmbH, the standard of care and personal liability of managing directors is set out in the Gesetz betreffend die Gesellschaften mit beschränkter Haftung (GmbHG), in particular § 43 GmbHG, which requires a Geschäftsführer to apply the diligence of a prudent businessperson and imposes liability for breaches. For the stock corporation (AG), the equivalent duties and liability of the management board are governed by the Aktiengesetz (AktG), notably § 93 AktG. General tort and contract claims, including damages actions by the company or third parties, draw on the Bürgerliches Gesetzbuch (BGB).
Where the company approaches or enters insolvency, the filing obligations and associated personal liability of directors arise under the Insolvenzordnung (InsO), the duty to file, and liability for payments made after insolvency maturity, are now consolidated principally in §§ 15a and 15b InsO.
The applicable fault threshold varies with the claim, some liabilities attach for ordinary negligence, others (and most insurance exclusions) turn on gross negligence or intent. Mapping which threshold applies to each identified risk is the analytical spine of any director liability m&a germany assessment.
D&O insurance germany is the primary tool for protecting individuals, but it is narrower than parties assume and behaves unpredictably at a change of control. Treating it as a self-executing backstop is the most common and expensive mistake in director liability m&a germany planning.
A German D&O policy generally responds to civil claims for financial loss arising from a wrongful act by an insured person, together with defence costs, often the most immediately valuable feature. Cover typically distinguishes management protection from entity cover for certain claims. Criminal fines and penalties are ordinarily excluded, though defence costs for the underlying proceedings may be advanced subject to policy terms and repayment provisions. Note that under German stock corporation law a mandatory deductible applies to management board members of an AG (§ 93(2) AktG); comparable retentions are commonly agreed for other insureds.
Because a share sale is usually a change of control, the incumbent D&O programme frequently converts into run-off by operation of a policy clause or lapses on renewal. Someone must decide who keeps cover in force, who pays, and whose interest the policy protects. Assignment of a policy or direct claims by a buyer generally require insurer consent and raise insurable-interest questions under the VVG. These points cannot be left implicit.
Run-off (tail) cover freezes protection for wrongful acts committed up to completion and extends the period in which claims can be notified, the extension is a matter of negotiation, and multi-year tails are common. It is the cleanest way to protect former directors for pre-closing conduct. In practice the seller buys run-off for the departing board as part of the exit, while the buyer arranges forward D&O, or a wrap, for continuing and incoming management. A W&I insurer will usually carve D&O-type management liability out of its own cover, reinforcing the need for a dedicated run-off buy.
The German prudential context for insurers is set by the Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin), with broader European market and supervisory trends tracked by the European Insurance and Occupational Pensions Authority (EIOPA).
There is no single correct structure, but there is a correct process: identify the specific exposures, then match each to the instrument that recovers fastest and cheapest. The four workhorse tools are the seller indemnity, buyer-purchased W&I, D&O run-off or wrap, and escrow. They are not mutually exclusive, the strongest deals layer them, but the table below sets out how each performs across the dimensions that decide a negotiation.
| Dimension | Seller indemnity (SPA) | W&I insurance (buyer’s policy) | D&O insurance (run-off / wrap) | Escrow / retained funds |
|---|---|---|---|---|
| Tax | Effect depends on the applicable tax regime; take tax advice | Premium treatment depends on circumstances; take tax advice | Treatment varies; buyer/seller allocation may affect deductibility | Timing and treatment depend on structure; interest may be taxable |
| Cost | Borne by seller through exposure, often priced into the deal | Buyer typically pays premium and bears the retention/deductible | Seller commonly funds run-off; buyer funds forward wrap | Seller funds from proceeds, reducing net cash at completion |
| Liability | Seller contractually liable, subject to caps, baskets, survival | Insurer liable to buyer under policy; seller exposure reduced | Insurer pays management, subject to exclusions and limits | Funds available up to the retained amount only |
| Timing | Claims run to SPA survival periods, often short | Covers claims within the policy period; discovery-driven | Run-off solves pre-closing acts; wrap covers forward risk | Immediate source, subject to release schedule |
| Enforceability | Contractual, weak if seller is insolvent or defunct | Direct claim on insurer; faster but subject to policy defences | Governed by policy; insurers may deny for non-disclosure/late notice | Easiest recovery, but capped at funds held |
| Negotiation edge | Buyers want breadth and long survival; sellers push caps/baskets | Buyers value clean exit; sellers prefer buyer-paid cover | Sellers retain existing cover; buyers press for run-off or wrap | Buyers secure a middle ground; amount tied to identified risks |
The instruments above only work if the SPA operationalises them. Below are model building blocks. They are illustrative, not off-the-shelf: adapt them to the deal facts, the FDI position under the Außenwirtschaftsgesetz (AWG) and the Außenwirtschaftsverordnung where relevant, and to counsel’s review.
A specific indemnity should ring-fence quantifiable exposures, for example director-level claims relating to pre-closing conduct, outside the general warranty regime:
“The Seller shall indemnify and hold harmless the Buyer and the Group Companies against any Losses arising out of or in connection with any claim brought against a person who served as a managing director or board member of a Group Company prior to Completion in respect of acts or omissions occurring on or before Completion, save to the extent such Losses arise from the fraud of the Buyer. This indemnity shall survive until the [·] anniversary of Completion and shall not be subject to the de minimis, basket or cap applicable to Warranty Claims.”
Key negotiation levers are the survival period (long enough to match D&O run-off), the carve-outs (fraud is standard), and whether the item sits inside or outside the general liability cap.
This clause ensures cover is not prejudiced by inaction, a real risk given the VVG’s notification regime:
“The Seller shall, and shall procure that each relevant former officer shall, provide all reasonable assistance necessary to give timely notice of any claim or circumstance to the relevant D&O insurers, preserve all relevant documents, and cooperate fully in the conduct of any resulting proceedings. The Seller shall not do anything that prejudices cover under any run-off or other D&O policy.”
Where the seller is to secure run-off, the SPA should convert that into a hard covenant with proof:
“On or before Completion the Seller shall procure a run-off extension of the Group’s directors’ and officers’ liability insurance for a period of not less than [·] years in respect of wrongful acts committed on or before Completion, on terms and for a limit no less favourable than the policy in force at signing, and shall deliver evidence of binding cover to the Buyer at Completion.”
Choose consciously between two positions. An offset approach prevents double recovery:
“The amount of any Loss recoverable under this Agreement shall be reduced by any amount actually recovered by the Buyer or a Group Company under any insurance policy, including any D&O or W&I policy, in respect of the same Loss.”
A non-reducing approach preserves the indemnity regardless of insurance and leaves subrogation to the insurers:
“The Seller’s liability under [the Director Indemnity] shall not be reduced or affected by the existence or availability of any insurance, and the Buyer shall be under no obligation to pursue any insurer before claiming under this Agreement.”
Where escrow secures identified risks, specify the amount, the release schedule (for example staged releases at defined intervals net of notified claims), the claim and set-off process, treatment of interest, and the dispute-resolution route. Tie the escrow amount to the quantified exposures rather than to a round percentage of price.
Even a well-drafted deal fails if the first claim is mishandled. The difference between recovery and a coverage denial is usually made in the first days after notice.
Control clauses should already answer this. Where the seller bears the loss through an indemnity, the seller often expects a consent right over settlement; where the buyer or insurer bears it, they will want control. The risk to avoid is a party that controls the defence but does not fund the outcome. Settlement thresholds and consent-not-to-be-unreasonably-withheld standards keep the mechanism workable.
A seller indemnity is only as good as the seller. If the seller is insolvent or has been wound up after distributing proceeds, the buyer must fall back on W&I or escrow, which is precisely why solvent-seller assumptions should be stress-tested at signing. Directors’ own conduct in the run-up to any insolvency can itself generate InsO liability, and insolvency clawback risk can complicate recovery from a distressed counterparty.
Only if the SPA says so. Absent an express offset clause, a seller cannot assume that a payment under a D&O policy discharges its indemnity, and a buyer cannot assume it can recover twice. This is a frequently litigated ambiguity in director liability m&a germany claims, and the offset or non-reducing language above should settle it at drafting stage.
Regulatory investigations sit awkwardly with insurance. Defence costs may be advanced, but criminal fines and many statutory penalties are non-indemnifiable and excluded from D&O cover. Where an FDI review under the AWG/Außenwirtschaftsverordnung or a regulatory inquiry is foreseeable, address the interaction expressly rather than assuming the policy responds.
Two shortcut rules for the room: if the seller refuses run-off and the historic conduct risk is high, insist on W&I plus a larger escrow. If the seller is thinly capitalised, do not rely on indemnities alone, move exposure onto an insurer or into escrow.
Getting director liability m&a germany right is a matter of sequencing, not guesswork: quantify each exposure, assign it to the instrument that recovers fastest and cheapest, and hard-wire the mechanics into the SPA. In most 2026 German deals that means a seller-funded D&O run-off for the departing board, a buyer-arranged forward programme or wrap for continuing management, specific indemnities for quantifiable risks, and W&I or escrow to cover the gaps and the risk of a weak counterparty. Decide the offset position, the survival periods and the defence controls at drafting stage, not when the first claim lands. For tailored advice on structuring director liability m&a germany protection in a live transaction, contact Dr.
Torsten Bergau, GLE profile, and see the Germany corporate practice page and the Germany M&A hub for related guidance.
This article is general information for 2026 and is not legal advice. The right structure depends on the specific facts of your transaction; obtain bespoke advice before relying on any clause or approach set out here.
This article was produced by Global Law Experts. For specialist advice on this topic, contact Torsten Bergau at FRANKUS Wirtschaftsprufer Steuerberater Rechtsanwalte, a member of the Global Law Experts network.
posted 21 minutes ago
posted 1 hour ago
posted 1 hour ago
posted 2 hours ago
posted 2 hours ago
posted 2 hours ago
posted 3 hours ago
posted 3 hours ago
posted 3 hours ago
posted 4 hours ago
posted 5 hours ago
posted 6 hours ago
No results available
Find the right Legal Expert for your business
Send welcome message